Harper Investing’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.26M Buy
1,090
+99
+10% +$117K 0.39% 50
2026
Q2
$1.19M Buy
991
+202
+26% +$206K 0.4% 52
2026
Q1
$726K Buy
789
+595
+307% +$603K 0.32% 55
2025
Q4
$209K Buy
+194
New +$185K 0.09% 65

Other funds holding LLY

Harper Investing's LLY Position: Q3 2026 in Review

Harper Investing increased its Eli Lilly (LLY) stake by 10% in Q3 2026, buying an estimated $117K and bringing the position to 1,090 shares worth $1.26M. The position accounts for 0.39% of the portfolio, ranked #50.

Harper Investing first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Harper Investing held 1,090 shares of Eli Lilly worth $1.26M as of Q3 2026.
  • Harper Investing bought 99 Eli Lilly shares in Q3 2026, an estimated $117K.
  • Eli Lilly made up 0.39% of Harper Investing's portfolio in Q3 2026, its #50 holding.
  • Harper Investing first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Harper Investing's 13F filing for Q3 2026, filed 22 Oct 2026.